{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:53:09Z","timestamp":1764251589826,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:00Z","timestamp":1560902400000},"content-version":"vor","delay-in-days":169,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2019]]},"DOI":"10.6061\/clinics\/2019\/e631","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T16:02:01Z","timestamp":1563206521000},"page":"e631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The evaluation of the Myxovirus Resistance 1 protein in serum and saliva to monitor disease activation in primary Sj\u00f6gren's syndrome"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8421-7287","authenticated-orcid":false,"given":"Yasemin Gul","family":"Aydemir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9685-6660","authenticated-orcid":false,"given":"Ahmet","family":"Kocakusak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9482","key":"10.6061\/clinics\/2019\/e631_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sj\u00f6gren\u2019s syndrome","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"10.6061\/clinics\/2019\/e631_bib2","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sjogren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sj\u00f6gren\u2019s syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.6061\/clinics\/2019\/e631_bib3","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/annrheumdis-2012-202552","article-title":"MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren\u2019s syndrome","volume":"73","author":"Maria","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.6061\/clinics\/2019\/e631_bib4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/BOR.0b013e32832eba21","article-title":"Pathogenesis of Sj\u00f6gren\u2019s syndrome","volume":"21","author":"Nikolov","year":"2009","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"10.6061\/clinics\/2019\/e631_bib5","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/rheumatology\/37.10.1069","article-title":"Sj\u00f6gren\u2019s syndrome: a community-based study of prevalence and impact","volume":"37","author":"Thomas","year":"1998","journal-title":"Br J Rheumatol"},{"issue":"4","key":"10.6061\/clinics\/2019\/e631_bib6","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/art.20998","article-title":"Activation of the type I interferon system in primary Sj\u00f6gren\u2019s syndrome: a possible etiopathogenic mechanism","volume":"52","author":"Bave","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.6061\/clinics\/2019\/e631_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1385\/CRIAI:25:1:89","article-title":"Immunopathogenesis of Sj\u00f6gren\u2019s syndrome","volume":"25","author":"Borchers","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"issue":"11","key":"10.6061\/clinics\/2019\/e631_bib8","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.3899\/jrheum.080418","article-title":"Upregulation of myxovirus-resistance protein A: a possible marker of type I interferon induction in systemic sclerosis","volume":"35","author":"Airo","year":"2008","journal-title":"J Rheumatol"},{"issue":"3","key":"10.6061\/clinics\/2019\/e631_bib9","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1186\/ar3895","article-title":"Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"14","author":"Sacre","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"46","key":"10.6061\/clinics\/2019\/e631_bib10","doi-asserted-by":"crossref","first-page":"80461","DOI":"10.18632\/oncotarget.19057","article-title":"Hydroxychloroquine and risk of cancer in patients with primary Sj\u00f6gren syndrome: propensity score matched landmark analysis","volume":"8","author":"Fang","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.6061\/clinics\/2019\/e631_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.rdc.2017.09.010","article-title":"Gastrointestinal and Hepatic Disease in Sj\u00f6gren Syndrome","volume":"44","author":"Popov","year":"2018","journal-title":"Rheum Dis Clin North Am"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222006275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222006275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:57:23Z","timestamp":1761721043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222006275"},"secondary":[{"URL":"https:\/\/www.clinicsjournal.com\/wp-content\/plugins\/xml-to-html\/include\/lens\/index.php?xml=1807-5932-clin-74-e631.xml&lang=en","label":"CLINICS"},{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1807-59322019000100237&lng=en&nrm=iso&tlng=en","label":"SCIELO"},{"URL":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6558995\/","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":11,"alternative-id":["S1807593222006275"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2019\/e631","relation":{},"ISSN":["1807-5932"],"issn-type":[{"type":"print","value":"1807-5932"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The evaluation of the Myxovirus Resistance 1 protein in serum and saliva to monitor disease activation in primary Sj\u00f6gren's syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2019\/e631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}],"article-number":"e631"}}